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Fibroblasts that tnigrate into a wound during the 
early stages of repair use cell surface integrins to 
interact with extracellular tnolecules as they tnove 
away frotn the interstitial tnatrix of nortnal tissue and 
into the provisional tnatrix of the wound. Therefore, 
to understand a critical phase of wound healing, it is 
necessary to understand the details of integrin in-
volvetnent. Nortnal adult hutnan dertnal fibroblasts 
in culture express tnany receptors for the provisional 
tnatrix proteins fibronectin, vitronectin, and fibrino-
gen, including the integrins a3/31, a4{31, a5{31, av{31, 
av{33, and av{35. We used quantitative flow cytOtn-
etry to estitnate the relative nutnbers of these recep-
tors and itnJDunoprecipitation to confirtn the expres-
sion of av{31. Adult hutnan derJDal fibroblasts 
pritnarily use {31 integrins, a4{31, a5{31, and possibly 
av{31, for attachtnent to fibronectin. av{33 and per-
haps other integrins containing the av subunit serve 
T he progress of cutaneous wound repair depends upon interactions be tween cells and the extracellu lar ma-trix. The blood clot that initially tiUs a wound is composed primarily of fibrin [1], but it also contains other components, notably fibronectin [1] and 
vitronectin [2]. After a lag of 3-4 d, the fibroblasts responsible for 
repairing a cutaneous wound migrate into the defect fi'om the 
surrounding uninjured tissue, and then secrete and deposit new 
matrix components [3] . Clearly, ce ll attaclmlent and migration both 
require interactions between the fibroblasts and the provisional 
matrix. 
Many interactions between cells and matrix proteins are medi-
ated by a large fami ly of ceU surface recep tors called integrins [4] . 
All integrins are composed of two subunits, one a and one {3. 
Although the binding activity and specificity distinctive of each 
in tegrin are de termined primarily by the two subunits forming the 
integrin, the funct ion of an intcgrin can also be influenced by the 
cell expressing it [5]. There are several examples where the same 
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fibroblasts as secondary or auxiliary receptors for 
fibronectin. In contrast, these cells use av integrins 
but probably not {31 integrins for attachtnent to 
vitronectin. av{33 and av{35 apparently act in concert 
to tnediate attachtnent to vitronectin, and these two 
integrins tnay perfortn different functions during 
wound repair. Fibroblast adhesion to certain prepa-
rations of fibrinogen occurs, at least partially, 
through the stnall atnount of fibronectin present in 
the preparations. Fibroblast attachtnent to fibrinogen 
purified free of fibronectin also occurs, and that was 
delDonstrated with a sensitive new assay called elec-
trical cell-substrate itnpedance sensing. Fibroblast 
attachtnent to pure fibrinogen can be inhibited by 
RGD peptide, suggesting that integrins are involved. 
Key woyds: wOlJnd yepait'/cell migrationljlow C)'tollletry/eiec-
tt'icai cell-slliJstt'ate impeda1lce se1lsing. ] lI/1!est Damato/ 
106:102-108, 1996 
integrin expressed in differen t cell types does not exhibi t the same 
functional characteristics in each cell type. First, in a human 
melanoma cell line a2{31 binds to collagen and laminin, but in a 
human feta l lung fibrobhlst it binds only to collagen [6] . Second, ill 
a particular carcinoma cell line where it is expressed by itself, Ci3{31 
mediates adhesion to fibrone ctin [7]. In certain cell types expressing 
both a3{31 and a5/31, however, O'5{31 is the domi.nant fibron ectin 
receptor and a3{31 contributes very little [7]. 
Our goa l here was to investigate the integrins used by normal 
human adult de rmal fibroblasts for interactions with wound provi-
sional matrix. A relatively large number of integrins are potential 
receptors for components of the provisional matrix . lntegrins a3{31, 
a4{31, O'5{31, av{31 (8,9J, and Civ{33 can aJJ bind to fibron ectin, 
although they do not all bind to the same site on fibron ectin [10]. 
Integrins O'v{31 [11,12J , av{33 [4,13], and O'v{35 [4,13J are reported 
receptors for vitronectin. Aside from tbe platelet integrin O'Jlb{33 , 
av{33 is also the onJy known integrin r eceptor for fibJ:inogen [14]. 
There is currently very little information availabl e identifying the 
integrins expressed by human adult fibroblasts or characterizing the 
binding specificity of those integrin s. 
In this re port, we demonstrate that normal adult human dermal 
fibroblasts in culture express the integrins a3{31, a4{31, a 5{31, 
av{31, av/33, and av{35, and we explore their relative contributions 
during fibroblast attachment to proteins of the provisional matrix. 
Our results provide more evidence that the functional characteris-
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tics of integ rins can v;u)' among different cell types . We present 
here the first full analys is of the integ rin s used b y norma l human 
adult dermal fibrob lasts tor adhesion to fibroll ectin , vitronectill , 
alld fibrinogen, impo r tant compo n en t's of th e w o und provisional 
matrix. 
MATElUALS AND METH O DS 
Matrix Proteins and Peptides Human vitro nectin. fibronectin , and 
a -chYl1lotryptic t 20-kDa fi'agment of fibroncctin were purchased fi'om 
Gm CO I3RL (Grand Island. NY). HUl11an fibrinogen was kindly provided 
by D. Ga lanakis (SUNY , Stony Brook. NY) and by M. Mosesson (S inai 
Samaritan Medical Center, Milwaukee, \ Xl I). o mmercia l human fibrino-
gen was purchased fi:o l11 C AL1310C HEM (La J o lla . CAl . 
The peptides GRGDSP and GRGESP were synthesized and purified by 
high perfonn;lnce liquid chromatography at the Cenrer fo r Ana lysis and 
Synthesis of Macromo lecules (SUNY. Ston)' I3rook). 
Cell Culture T he fo llowing cultures of no rmal adult human derma l 
fib roblasts were obta ined from the NIA Aging Cell ulture R.epository. 
Cori ell Institute for Medi coII Research (Camden. NJ): AG02602A. 
AG04145, AG0444 I A, AG04453, AG0747 1. and AG07473 . All tibrob last 
cultures were maintained at 37°C in minimum essential medium (#410-
1600, GIBCO I3R .. L) contilining 4 IllM sodium bicarbonate , 30 111M H EPES, 
100 U/ml penici llin , and 100 iJ.g/ml strcptor;lycin . supplem ented with 10% 
or 20'X. fe ta l bovine serum (Atlanta Biologicals, Norcross, GA) and w ith 
additional essential amino acids (#320 -1 \35, G IBCO B1U) . nonessen tial 
amino acids (#3 20-1140). and v itamins (#320-1120). 
Antibodies Two difFe rent rabbit po lyclonal antibodies that recognize the 
av subunit were used in this work. O ne antibod y speci fi call y recognizes 
only the cytop\;l smic tail of av [15]. and it was used for detecring a v by 
immunoblotting. It was not used for inhibition stud ies . The o ther antibody 
again st the av subunit . rai sed against intact receptor 11 6 1. is a potent 
inh.ibitor of the fun ction of c,v integrillS. Monoclonal antibodies specific for 
illtegrin subuni ts e,3 (1'1135). a4 (P4G9. P4 C2) . as (l'lD6), and integrin 
av{35 (Pl F6) we re o bta ined fi'o m G IB CO 13 I'lL. whi le an an tibody specific 
for {31 (4134) was purchased fro m C oulter Immun ology (Hia leah, FL). 
Additiona l monoclona l antibodies spec ific for integrins o r individual sub-
units were generously provided by the fo llowing investig'ltors : anti-a5{3 1 
(MoAb 16) and anti-{31 (MoAb l 3), K. Yamada, National Institute of 
Dental Research, Bethesda, MD; anti-e, v ( 13C2) and anti-av{33 (23C6), M. 
Horton , Imperial Cancer R.e search Fund , Londo n. U.K. ; anti-{33 complex 
(7E3), 13 . Coller. State Unive rsity of New Y ork at Stony Brook, Stony 
Bro ok , NY; anti-a v{33 (LM609) and anti-c, v{35 (P3G2). D. C hercsh. 
Research Institute of Scripps C linic, La Jolla , CA. Polyclo nal rabb it 
anti-fibronectin was purchased 6'om Dako (Carpinteria. CAl. 
Quantitative Flow Cytometry C ultures of fibrobla sts were dispersed 
with 0.05'X, trypsin /O.02% EDTA. Trypsin was inactivated by the add ition 
of a 2-fo ld excess of soy bean trypsin inhibito r in phosphate-bulfered sa line 
(PBS) containing 0. 2'V" bovine serum albumin (I3SA), and the ceUs were 
washed tw ice ill sCf'ulll-fn.:c cul ture 111CdiuIll containing O. 2lX, nSA. T he 
washed ce lls we re resuspended to a concentratio n of 1 U-12 X 10" ce lls/1ll1 
in cold Hanks' balanced salt solution (#H-4891; Sigm a C hemical Co .. St. 
Lo uis, MO), containing 0.2% BSA and 0.2% sodiu m az ide (FC medium) . 
The resuspended ce ll s were then mixed with 'I, vo lume of a b lockillg 
solu tio n contai ning 10 mg/ ml human y-globulins (#G- 4386, Sigma) and 
0.2% sodium azide in Hanks' balanced salt so lution. After incuba tion for 10 
min o n icc. 50 iJ.1 aliquots of the cell suspensio n were transferred to tubes 
containing 50 JJ.I of primary antibody diluted in FC medium . The ce ll 
suspension was mixed gently with the antibody and then incubated for 60 
min on icc. At this stage , the ce ll concentration was abo ut 5 X 10' ce llshul 
and the primary antibody (ascites or I mg/ml puri fied imlllllnoglobulin) was 
typica ll y present at a d ilu tion of I :200. After 60 min, 2 III I of cold FC 
medium W'IS added to each tube; the tubes were centrifuged to pellet the 
ceUs; and then the cell s we re washed once aga in with co ld FC mediulll. The 
washed cell s were resuspended in 50 iJ.1 o f secondary antibody di lu ted in FC 
medium , mixed gentl y, and incuba ted for 30 min o n icc . T he secondary 
antibodies . flu orescein iso thiocyanate conjugates of goat anti-Illo use IgG 
(#M3S001) and goat anti-rat IgG (#R4040l), supplied by Ca ltag Labora-
tories (South San Francisco, CAl . were di luted 1 :50. A fter 30 min . 2 ml of 
cold FC medium was added to each tube; the tubes were centrifuged to 
pe llet the stained ce lls; and then the ce ll s were fi xed for 20 min on icc with 
0.5 ml of Pl3S containing 1 % para formaldehyde. After (·ixation. 2 m l of co ld 
PBS p lus 0.04% sodium azide was added to each tube; the tubes were 
centrifuged to pell e t the cells; and then the fixed cell s were resuspended in 
0.5 ml of co ld PBS plus 0.04% sodium azide. Fixed , stained ce lls were stored 
at 4°C until analysis . 
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T he ce ll surface expression of integrins was analyzed by quantitative flow 
c)'l'o metr)' perform ed with a FACStar Plus cell so rter (Becton D ickinson 
Immunocytometry Systems. San J ose, CAl runlling L YSYS II software . 
Samples were gated by forward and side scatter only to exclude cell 
aggregates and cell debri s. Fluorescein isothioc),anate microbead ca libration 
srandards were supplied b )' Flow Cyrornctry Standards Corporation (San 
.Juan . PR.). Calibration standards allow fu r the conversion of relative 
fluorescence in tensity into an abso lu te va lue. tile number of molecules of 
equivalent so luble fluorochrome (MESF) 11 7.1 . T he results reported he re arc 
given as the caIculnted MESF va lue fo r e'l ' h experimen tal sa mple minus the 
MESF value for the appropriate antibody control. Although MESF va lues 
arc quite useful fo r comparing the rela tive am o unts of different intcgrins 
p 81, we sho uld emphasize tllat an MESF value docs nOt represent the actua l 
number of integ rin molecules because the MESF value is rdated to the 
Illllnbc r of antigelllllolcClllcs but it is not theorcti caJl y cqu;11 [0 that ll ulllbcr. 
IItll11unoprecipitation and Western Blotting The biotinylation of 
fibroblast ce ll surf.,ce proteins and the subsequent immunoprecipi tations 
were performed as previously described 1191 except that the lysis and wash 
buft~r consi sted of 50 mM Tris-H C I, pH 7 .5, 150 mM NaCI. 0.1% Tween 
20 . 0.1 % sodium dodcc)'1 sul f.,te. and 0.5% sodium deox),cholate. Western 
b lots were also pre pared as desc ribed ea rli er. 
Cell Attachment, Standard Assay T he assay for measu ring fib roblast 
ad hesion to matrix pro teins was perfo rmed essentia ll y as described P 9 1. 
except that the cell concentratio n was lowered to 100,000 ce lls/rnl Or 
I U.OOO cells/well. In all experiments ce ll s were all owed to artach for 60 min 
at 37°C before the unattached cell s were washed awa y and the attached ce ll s 
we re fixed with 2% glutara ldehyde. After fixation. the attached cell s were 
air dried at room temperature and then 100 iJ.1 of O. I % crys tal vio let in 0.2 
M bo ric acid, pH 9, was added to each we Ll and the micro tite r plate was 
shaken at 600 rpm 0 11 a plate mixe r fo r 20 min. (The staining so lution was 
prepared fi'esh from a stock solu tion of 5% crysral vio let in 20% metllanol.) 
Excess stain was removed by tlu'ee washes w ith water. T he sra ined cells 
were aga in air d,;ed before the crysta l vio let was solubi li zed by add in g 100 
iJ.1 of 10')'0 acetic acid to each well and then shaking the plate at 600 rpm for 
20 min . T he absorbance at 590 nlll was measured with a dua l wave length 
microtiter plate reader (THERMOmax; Mo lecular Devices. Menlo Park. 
CAl and that reading was corrected for light sca ttering by subtraction of the 
absorba nce at 450 'lIll. 
Cell Attachment: Electrical Cell-Substrate Impedance Sensing 
Electrica l ce ll-substrate impedance sensing, a new lIlethod referred to as 
EC IS. supplies quantitative info rma tion about the attachment, sp reading. 
and movem ent of cell s ill .. i fm [20 - 22]. The sensing device consists of a 
small gold electrode deposited at the bottom of a tissue culmre wel l. T he 
electrode is fi rs!' coated with a purified prote in to provide an adhesive 
substrate and then ce ll s arc added . \Xl hen the ce lls attach and spread on the 
e lec trode. the measured impedance changes bccause the cell s act as 
insu lating particles and interfere with current flow ro the electrode . These 
changes in inlpcdancc reflect the dYllarnic interactions bct"vCC J1 the cell s and 
the substrate . 
EC IS instrumentatio n was purchased from Applied BioPhys ics (Troy. 
NY). Each eleen'ode assembly ho.lds five separate we lls which can be used 
simul taneously for independent m easurements . Electrode well s were coated 
w ith ad hesive prote ins and subsequently blocked with BSA as described fo r 
the standard cell attachment assay [1 91· Cultures of tib roblasts wcre 
di spersed with 0.05'X. trypsin /0 .02% e thylenediamine tctraacetic acid . Tryp-
sin was inactivated by the addition of a 2-fo ld excess of soy bean trypsin 
inhibito r in PBS containing 0.2')10 I3SA, and the cell s were washed twice in 
CO2- independent culture medium (# 18045-021. GIBCO 13RL) containing 
0. 1% I3SA. Fina ll y. the cdls we re resuspended in CO 2-independent culture 
medium containing 0 .1 % BSA . A 200-iJ.1 aliquot of ce ll suspension was 
added to each we ll , the top was overl aid with a few drops of minera l oil to 
contro l evaporation . and the electrode assembly was placed in a 37°C 
incubator w here a 4,000-Hz signal with 1-V amplitude waS app li ed. 
Measurements fi'om each well were recorded approximately every 30 s. 
Kesul ts an: presented as the resistance norm alized to the resistance mea-
stll'cd ini tially at tim e zero. Ini tial res ist'lI1 ce was typicall y around 2.000 
o hms. 
RESULTS 
Fibroblast Receptors for Provisional Matrix Proteins A 
numbe r of difFe re nt in tegrin s a rc potential recepto rs for fibronectin, 
v itronectin, and fibrino gen , th e three m ajor con stituen ts of prov i-
sional matrix. We u sed quantitative Aow cyto m e try to identi fy the 
integrin s expre ssed b y n o rm a l hum an adul t d ermal fibroblasts . 
Table I slImm arizes quantitative fluorescen ce- activated cell sor ter 
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Table I. Quantitative Fluorescence-Activated Cell Sorter 
Analysis of Integrins Expressed ill Vitro by Normal Human 
Adult Dermal Fibroblasts" 
MESP" 
(number of 
moleculesl cell 
Antibody lntegrin Subunit(s) [X10- ')) 
PiB5 a3 93 
P4G9 a4 9 
P4C2 a4 7 
P1D6 as 55 
4B4 {31 275 
23C6 av{33 16 
LM609 av{33 15 
7E3 {33 15 
P3G2 av{35 6 
P1F6 av{35 7 
13C2 av 95 
"A culture of fibroblasts (AGOZ60ZA) rrolll a 35- year-old female donor was 
analyzed by quantitative Aow cytomctry for expression of the indic:lted integrins lIsing 
specifi c monoclonal antibodies. 
1/ The MESF value is explained in J\I[ateritils (/1/(/ N1rf/wt/s . 
data showing that normal human adult dermal fibroblasts in culture 
expressed detectable levels of a3{31, a4{31, as{31, av{33, and av{3S. 
We could not directly estimate the number of av{31 receptors with 
tllis techrllque because there is no monoclonal an tibody currently 
available that is specific for the av{31 combination . Our observa-
tion, however, that the number of av subunits was greater than the 
total number of av{33 and av{3S integrins (Table I) suggested that 
av{31, and perhaps other integrins containing av, were also present. 
Therefore, we used immunoprecipitation to confirm the existence 
of av{31 (Fig 1). An antibody specific for the {31 chain precipitated 
a 
Subunits [ 
+av 
Figure 1. Immunoprecipitation demonstrates that fibroblasts ex-
press avf31. Fibroblast cell surface proteins were labeled by biotinylation 
and then cell lysates were incubated with anti-{31 monoclonal antibody 4B4 
to precipitate the {31 subunit and all of the a subllllits associated with it. The 
nitrocellulose blot of olLe sample (I'!1i pnlle!) Was incubated with streptavidin-
alkaline phosphatase to reveal all of the precipitated subunits. The blot of an 
identical sample (righ' pnuel) was incubated first with a rabbit antibody 
specific for the cytoplasmic tail of CiV [15], and then with an anti-rabbit IgG 
secondary antibody conjugated to alkaline phosphatase. 
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several a chains. One of the a ch'lins was unequivocally identified 
as av by an antibody specific for the cytoplasmic tail of the av 
subunit. 
Adhesion to Fibronectin The fibroblast integrins responsible 
for attachment to a given ligand can be identified in a cell 
attachment assay by using antibodies to specifically inllibit the 
function of individual integrins. First, we exa nlined adhesion to 
fibronectin. Most integrin interactions with fibronectin are re-
stricted to two different sites on the fibronectin molecule [10] . 
Tntegrins a3{31, as{31, av{31, a.nd av{33 recognize the arginine-
glycine-aspartic acid (RGD) amino acid sequence found in a 
120-kDa proteolytic fragment of fibronectin; a4{31 recognizes a 
site, within the type III connecting segment, that is not found in the 
120-kDa fragment. Since we recently demonstrated that a4~1 
mediates fibroblast adhesion to the non-RGD site on fibronectin 
[19], in tllis paper we focused on a further investigation of the 
fibroblast integrins that m ediate attachment to the RGD site. A 
monoclonal antibody that blocks the function of integl;ns contain-
ing the {31 subunit and a monoclonal antibody that specifically 
blocks as{31 each strongly inhibited attachment to the 120-kDa 
fragment of fibronectin (Fig 20). In contrast, a polyclonal antibody 
that recognizes integrins conta ining the av subunit [1 6] produced 
very little inllibitiol1 when used alone (Fig 2a) . Combining the 
anti-av antibody with the anti-aS antibody, however, produced 
siglli .. ficantly greater inhibition than that produced by anti-aS alone 
(Fig 2b). Since that observation suggested that an av integrin may 
serve as a secondary Or auxiliary receptor for fibronectin, we 
attempted to determine wllich av integrin was involved. N either 
anti-{33 nor anti- av{3S inhibited attachment to the fibronectin 
fragment when used alone (Table II). When combined, however, 
with anti-aS, anti-{33 clearly increased inhibition but anti-av~5 
apparently did not. 
Adhesion to Vitronectin We also used inllibitory antibodies 
for studying fibroblast adhesion to vitronectin. The polyclonal 
anti-av antibody strongly i.nllibited adhesion to vitronectin, while 
the monoclonal anti-{31 antibody and a control antibody had no 
effect (Fig 3). The polyclonal anti-av antibody may be particularly 
effective beca use it inhibits severa.l integrins simultaneously. Mono-
clonal antibodies specific for av{33 and av{3S had little effect when 
used alone, but when used together they produced very strong 
inhibition (Table III). 
Adhesion to Fibrinogen Finally, we examined fibrobla st inter-
actions with fibrinogen. We began this part of our study by 
evaluating a number of differen t preparations of fibrinogen because 
initially we had trouble obtaining reproducible attachment in our 
standard assay. Western blots stained with anti-fibronectin anti-
body indicated that there was a clear correlation between fibroblast 
adhesion to a pa.rticular fibrinogen preparation and the presence of 
fibronectin in that preparation (Fig 4). One group of fibrinogen 
preparations, C lass 1, promoted very little adhesion in the standard 
assay and contained no detectable intact flbronectin; the other 
group, C lass 2, promoted substantial fibroblast adhesion and COIl-
tained manifest fibronectin. Subsequent experiments established 
that fibroblast attachment to class 2 fibrinogen was at least partially 
mediated by the fibronectin found in those preparations. Cell 
attachment to class 2 fibrinogen was inhibited by treating the 
fibrinogen substrate with a monoclonal antibody against fIbronec-
tin, or by removing fibronectin from the fibrinogen preparation 
using gelatin affinity chromatography (data not shown). 
Although fibl:oblast interactions with fibrinogen pllJ;fIed fi'ee of 
fibronectin were not apparent in our standard adhesion assay, they 
were detected with the new technique called e lectrical cetl-
substrate impedance sensing [20 -22] . In this assay fibroblast attach-
ment to fIbronectin and vitronectitl was readily detected witllin 30 
min (Fig 5). Attachment to fibrinogen was clearly detectable after 
60-90 min and the m easured interactions with fibrinogen contin-
ued to increase for about 8 h, until fibrinogen was comparable to 
fibronectin and vitronectin. There was no m easurable attachment 
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Figurc 2. av intcgrins contributc to thc adhcsion of fibroblasts to 
tbc 120-kDa fragmcnt of frbroncctin. Substrates were coated with 5 
IJ.g/ml of the 120-kOa fragment of fibronectin. Cell s were mixed with no 
antibody, with controllgG. or with antibodies again st the indicated in tegrin 
subunits for 10 min before the cells were used in the ad hes ion assay . T he 
antibodies used were monoclonal 13 (anti-{:lI). monoclonal 16 (anti-aS). 
and po lyclonal anti-av in tegrins [1 6]. a) Enor bars, SO (n = 4). (J) Cell s were 
treated with the indicated concentration of anti-aS either alo ne (0 ) or in 
combination with 10 IJ.g/ ml anti-av (e). Results arc expressed relative CO 
the attachment of ce ll s treated with control IgG (2.2 X 10J cell s) and were 
calculated from the m eans (n = 5). 
to the control substrate BSA at any time. Each a chain of the 
fibrinogen hexam er con ta ins two different RGD sequences [23], 
and RGD sites have been implicated in the attachment of a variety 
of oth er cell types to fibrinogen [24,25]' T herefore, we used the 
EClS assay to determin e if fibroblast attaclU11ent to fibr inogen can 
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Table II. av and 0'5 Integrins Mediate Fibroblast 
Adhesion to the 120-kDa Fragment of Fibronectin" 
None 
Control 
An.ti-aS 
A nti-av 
Anti-{:l3 
Anti- av{:l5 
An ti body 
Anti-aS + anti-av 
Anti-aS + anti-{:l3 
An ti-aS + anti-a v{:lS 
Anti-a S + anti-{:l3 + anti-av {:lS 
Number of Cell s 
Attached 
( X 1 0 - 3)1, 
2. 1 :t 0.23 
2.3 :t 0.36 
1.2 :t 0.42' 
1.9 :t 0.21 
2 .0:t 0.16 
2.5 :t 0.34 
0.20 :t 0.06' 
0.36 :t 0 .09' 
1.39 :t 0.56' 
0.48 :t 0 .1 3" 
I I Substrates were coated with 5 J.lg/ ml of the 120-kDa fragment offibroncccin . Cells 
wcre mixed with 11 0 antibody, with con tro l IgG. or w-ith antibodies against the 
indic;ltcd intcgrin sub units for to min beforc thc cells wcre lIsed in the adhesion ass:ly. 
T he antibodies used were monoclonal t 6 (anti-aS), polyclonal anci-av integrins. 
monoclonal 7E3 (nnti-{33) , and monoclonal PI F6 (an ti-<Yv{35). 
" Results arc presentcd as mea n :t SO (n = 5). 
r p < 0.05 by analysis of variance. 
be in hibited w ith RGD peptide (Fig 6). T he peptide GRGDSP 
completely eliminated fibroblast interaction with fi brinogen over 
the 12-h course of the assay, while the control noninhibitory 
peptide GRGESP had only a slight effect. 
DISCUSSION 
In tillS report, we dem o nstrate that cultured human fibroblasts 
express tl1e i.ntegrins O'3{31, O'4{3 1. , as{31, O'v{31, O'v{33, and O'v{3S, 
and we explore their relative contributions during cell attachment 
to fibronectin, vitronectin, and fibrinogen, three important com-
ponents of the wound provisional matrix. Fibroblasts that migrate 
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Figure 3. av intcgril1s bnt not {31 intcgrins are rcquircd for fibro-
blast adhcsion to vitronectin. Substrates were coated with the indicated 
concentrations of vitronectin . Cell s were treated w ith antibodies as de-
sc ribed in the legend fo r Fig 2. Anti-av in tegrins (0 ). Cells only. no 
anti body added (A). Control IgG (6 ). Monoclonal 14 anti-{:l1 (e). En'OJ' 
bars, SO (n = 4). 
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Table III. IXv/33 and av/35 Mediate Fibroblast Adhesion 
to Vitronectin" 
Antibody 
None 
Control 
Anti-av 
Anti-{33 
Anti-av{33 
Anti-av {35 
Anti-av{35 + anti-{33 
Anti-av{35 + an ti- av{33 
Number of Cell s 
Attached 
(X 1 0- 3)', 
1.8 :':: 0.35 
1.8 :':: 0.14 
0.70 :':: 0.33' 
1.5 :':: 0.24 
1.8 :':: 0.42 
1 .8 :':: 0.45 
0.27 :':: 0. 10' 
0.70 :':: 0.30' 
(/ Su hstrates were coated w ith 5 lJ.g/ml vitroncctil1 . Cell s were trc.ltcd w ith 
antibodies as described in Table II . T he antibodies used were polyclonal il ll ti-c:t:V 
in tcgrins, monoclonal 7E3 (anti-{:!3). monoclonal LM609 (anti-av{:!3), and monoclona l 
P I F6 (al1ti-av/35) . 
I . Resu.lts arc presented as mean ± SO (II = 5) . 
,. p < 0.0 I by analysis of variance . 
in to a wound during the early stages of repair use cell surface 
integnns to in teract w ith extracellular m olecules as they move away 
from the illterstitial matrix of normal tissue and i.nto the pmvisional 
matri x of the wound , T herefore, to understand a critical phase of 
a 
Fibrinogen Class 1 Class 2 
Fibroblast 
Adhesion + + + + 
2 3 4 5 6 7 8 9 
b 
Figure 4. F ibronec tin is present in fibrinogen preparations that 
promote cell adhesion in the standard assay. II) Eight different 
preparations of fibrinogen, obta ined from the sO ll rces li sted in Materia ls allri 
Melltods , were first segregated into class 1 or class 2 depending upon their 
ab ili ty to promotc nd hes ion in the standard ce ll attachment assay. - , ce ll 
attachment to that tibrinogen prepar:.tion was not significantly differcnt 
from nonspec ific attachment to BSA. b) These fibrinogen prepa rations werc 
then analyzed for thc prescnce of fi broncctin by Western blotting. Purified 
fibroncctin , 0.2 fl.g (Iall e "I). four ,,""ples of C lass 1 (Inlles 2- 5) and Glass 2 
fibrinogen (Ialles 6-9), 10 J.Lg each , were applied to a 7 .5'X, polyacrylamide 
gel under reducing conditions, and thcn the resolved proteins were 
transren·ed to rtitrocellulosc blots fo r staining w ith polyclonal anti-fibronec-
tin antibody. 
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Figure 5. Electrical cell-substrate impedance sensing reveals that 
fibroblasts interact with class 1 fibrinogen. ECIS well s were coa ted 
with 300 J.Lg/ml DSA (6 ), 30 fl.g/ml fibronectin (e). 30 J.Lg/ml vitroncctin 
("'), or 300 fl.g / m l class "I fibrinogen (0). A 200-J.L1 aliquot, containing 
75,000 cells, was added to e:.ch wcll and readings wcre recorded for 12 h. 
Plotted here is the normalized resistance for each well at 30-l11in intervals. 
wound healing, it is necessary to unde rstand the details of in tegrin 
involvement, We believe that these studies ;/1 I1i/ro are relevant to 
wound fibroblasts ;/1 11 ; 110 beca use norm al fibroblasts in culture 
express many phenotypic characteristics of early wound granulation 
tissue fibroblasts [26] . However, these studies also ha ve inherent 
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Figure 6. RGD peptide inhibits fibroblast interactions with class 1 
fibrinogen. ECIS wcll s were coated wjth 300 fl.g/m l class 1 fibrinogen. 
Defore addition to the wells, ccll s were mi.-xed with PBS (GeJIIlro/) or with 
peptides dissolved in PBS, 100 fl.M GRGDSP (+RGD), or 100 J.LM 
GRGESP (+ RG£). A 200-J.L1 aliquot, conta ining 50,000 cells, was added to 
each well. 
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limitations. Cultured cells undoubtedly are affected by cuJture 
conditions, and so th e relative amounts of the integrins expressed 
by fibrob lasts in culture may differ from the amo unts expressed in 
tissue. Furthermore, the provisionaJ m atrix confronting fibrobla sts 
in an actual wound is a complex 3-dimensional constru ction that 
cannot be reproduced in simple adhesion assays. Fibroblast in ter-
actions with rea l provisional matrLx may be more labyrinthine than 
they appear from assays of cell attachment to simple substrates. 
We used quantitative flow cytometl), to establish th e relative 
levels of 0'3 (31, 0'4(31, 0'5(31, O'v (33, and O' v(35 expressed by normal 
adult human dermal fibro blasts in culture. The expression of O'v(31 
was confirmed by immunoprecipitation. T he three O'V integrins 
identified here on adult htu11an dermal fibroblasts, O'v(31, O'v(33, and 
av(35, have also been found on human gingival and granulation 
tissue fibroblasts [27], and on embryonic fibroblasts [28] . 
Fibroblasts use (31 integrins as the primary receptors for fibro nec-
tin and O'v integrins as secondary, or auxiliary, receptors . We have 
shown previo usly that 0'4(31 and 0'5(31 both m edia te fibroblast 
adhesion to fibron ectin [19]. We confirm here that (31 integrins are 
required and present evidence indicating that O'v integrins aJso 
participate . A lthough the polyclonal antibody directed against O'V 
integrins did not inhibit adhesion w hen used alone, it did produce 
significant inhibition w hen combined with th e anti-0'5(31 antibody. 
T his finding suggests that O'5 {31 on fibrobl asts is the pl;mal)' 
receptor for the RGD site in fibro nectin and tha t O'v(33, and pe rhaps 
o ther O'v integrins, are auxjbary receptors for the site . It has already 
been estabbshed that 0'5(31 and O'v (33 act in concert as fibron ectin 
receptors on othe r cell types, such as endothelial cells [29] and 
melanoma cells [30]. In addition , it seems likely that O' V {31 is aJso 
involved because O'V {31 has been identified through several different 
approaches as a recepto r for fibronectin [8 ,9 ,28]. W e can not 
d irec tly assess its contribution to fibroblast adhesion, howe ver, unti l 
in hibitory antibodies specific for O'v{31 becom e available. Finally, 
a ltho ugh thel'e is som e evidence that (35 integrins can function as 
fibronectin receptors [31,3 2], in our assays the anti-O'vf35 m ono-
clonal antibody had no effect on adhesion to fibron ectin . 
Cultured human dermal fibrobl asts use at least two O'v integrin s, 
O'v{33 and Cl'.v{35, for attachment to vltronectin . T hese two receptors 
appea.r to function independently since inhibi ting e ither integrin 
alone had little effect on adhesion, but inhibiting both together , 
either by a combination of m onoclonal antibodies o r by the 
polyclonal anti-O'v, reduced adhesion dramatically. Altho ugh O'v(33 
and O'v(35 both m ediate fibro blast adhesion to vitronectin ill lIilro, it 
is possible that they make distinct contribu tions durin g wound 
repair ill lIillo. For example, O'v{35 regulates the internabzation and 
degradation of vitronectin bound to thc cell surf;lce, but O'v{33 does 
not [33] . T lus fun ction of O'v{35 could obviously contribute to the 
matrix remodeling that accompanics wound repair. Furthermore, 
O'v(33 is concentrated into fo cal contacts when m elanoma cells and 
lung carcinoma cells interact with vitronectin, but O'vf35 is no t [1 3] . 
Since fo cal contacts are si tes of rela tively tight adhesion, fibrobl asts 
llugracing quickly into a wound may pre fer O' v(35 for interactio ns 
w ith vitronectin to avoid the potentially tighter interactions medi-
ated by O'V (33. 
Data colJected through the sensitive new technique calJed elec-
trical cell-substrate impedance sensing indicate that fibroblasts 
attach to purified fibrinogen thJ"ough a m echanism involving R GD 
recognition sites. Fibro blasts attached quite w ell to some fibrin ogen 
preparatio ns, referred to here as class 2 , but th ose preparations all 
contained small amounts of fibronecti n. The other group of 
fib rinogen prepanltions, dubbed class 1, contained no detectable 
intact flbronectin and promoted vcry littl e adhesio n w hen used as 
substrates in o ur sta ndard assay. When uscd in the EClS assay 
[20 - 22], however, the same preparations clearly pro m otcd attach-
ment. B ecause the conditions of the standard assay are f.1 irly 
rigorous it m ay not detcct the relatively weak interactio ns measured 
by the more sensitive EC IS assay. EC IS also revealed that fibrobla st 
attachm ent to purc tib rinogen can be inhibited by RGD peptide. 
T hat observation strongly suggests that integrins are involved, but 
the specific receptors have not yet been identifi ed. The most likely 
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candidate is O'v(33, which serves as a fibriu ogen receptor on 
m elanoma cells [25] and o n endothelial cells [24]. 
Adult human derm al fibroblasts appear to use two integrins, 
O'v(33 and O'v(35, for attachment to vitro nectin, and at leas t four 
different integrins, O'v{31 , 0'4{3 'J, 0'5{31, and O'v{33, for adhesio n to 
fibron ectin. One reason for this apparen t redundrulcy is that 
although several difFerent integrins m ay all bind to the sam e ligand, 
each of those integrin s may aJso regu1nte different intra cellular 
signal transduction pathways [34 J. Integrin-dcpcnden t signaling 
pathways are probably crucial for normal wound repair. For 
example , coopera tive signaJing through 0'4(31 and 0'5(31 plays a 
dominant role in regulating collagenase and stromelysin gene 
expression in rabbit synovial fibrob las ts [35- 37] . These proteases 
may play an important role in the matrix rem odeling that accom-
panies woun d repair. 
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